Morgans Life Science Index
About the author:
- Author name:
- By Scott Power
- Job title:
- Senior Analyst
- Date posted:
- 07 July 2014, 10:40 AM
- Sectors Covered:
- Healthcare, Life Sciences
The Healthcare and Life Science sector are showing strong signs of rising investor interest. If you look at our Morgans Index below both prices and volumes are picking up across our coverage universe:
At the larger end of the market the Healthscope IPO is sparking interest, together with Japara Healthcare (JHC) and Virtus Health (VRT).
At the smaller end Alchemia (ACL), Impedimed (IPD) and Admedus (AHZ - recently added to our high conviction stock list) have good momentum and are approaching significant milestones.
Others worth noting include:
- Neuren Pharmaceutical (NEU) - concussion trial update
- Rhinomed (RNO) - up 70% last week and going higher
- Invion (IVX) - interim trial update
- Acrux (ACR) - quarterly numbers should be stronger and paying a big final dividend
More information
Morgans clients can access our detailed research on all companies in the sector under coverage. If you are interested in finding out more, please contact your nearest Morgans office.
Disclaimer(s): Analyst may own shares in some or all of these companies.
The information contained in this report is provided to you by Morgans Financial Limited as general advice only, and is made without consideration of an individual's relevant personal circumstances. Morgans Financial Limited ABN 49 010 669 726, its related bodies corporate, directors and officers, employees, authorised representatives and agents (“Morgans”) do not accept any liability for any loss or damage arising from or in connection with any action taken or not taken on the basis of information contained in this report, or for any errors or omissions contained within. It is recommended that any persons who wish to act upon this report consult with their Morgans investment adviser before doing so.
-
Print this page
-
Copy Link